IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $824,330 | +72.7% | 20,954 | +6.8% | 0.00% | +100.0% |
| Q1 2023 | $477,403 | +22.6% | 19,622 | +7.9% | 0.00% | 0.0% |
| Q4 2022 | $389,319 | +68.5% | 18,184 | +41.3% | 0.00% | +100.0% |
| Q3 2022 | $231,000 | +86.3% | 12,868 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $124,000 | -43.4% | 12,868 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $219,000 | -32.0% | 13,005 | -32.5% | 0.00% | -50.0% |
| Q4 2021 | $322,000 | -1.2% | 19,261 | -4.1% | 0.00% | 0.0% |
| Q3 2021 | $326,000 | +160.8% | 20,082 | +1.3% | 0.00% | +100.0% |
| Q2 2021 | $125,000 | +1.6% | 19,828 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | -7.5% | 19,828 | +2.8% | 0.00% | 0.0% |
| Q4 2020 | $133,000 | – | 19,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |